TY - JOUR
T1 - Patient-reported outcomes with hypoglossal nerve stimulation for treatment of obstructive sleep apnea
T2 - a systematic review and meta-analysis
AU - Braun, Marcel
AU - Stoerzel, Manuel
AU - Wollny, Mathias
AU - Schoebel, Christoph
AU - Ulrich Sommer, J.
AU - Heiser, Clemens
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/10
Y1 - 2023/10
N2 - Introduction: Hypoglossal nerve stimulation (HNS) has recently been introduced as an alternative treatment for patients with OSA. A large number of studies have demonstrated substantial changes in OSA with this therapy by reducing respiratory events and improving symptoms such as daytime sleepiness and quality of life. The objective of this review was to conduct a systematic review and meta-analysis to evaluate patient-reported outcomes and experience with HNS therapy. Methods: A systematic literature search of MEDLINE, Cochrane, and Web of Science was performed to identify randomized controlled and observational studies reporting subjective outcomes with different HNS systems in patients with OSA. Abstracts of 406 articles were screened and a subset of 55 articles were reviewed for eligibility. Risk of bias was assessed using the ROBINS-I tool. Meta-analysis using RevMan was performed when > 2 studies were identified that reported data on a specific outcome. Results: Thirty-four publications reporting data on 3785 patients with a mean follow-up of 11.8 ± 12.2 months were identified and included in the meta-analysis. The analysis revealed a pooled effect of 4.59 points improvement in daytime sleepiness as measured by the ESS questionnaire (Z = 42.82, p <.001), 2.84 points improvement in daytime functioning as measured by the FOSQ score (Z = 28.38, p <.001), and 1.77 points improvement in sleep quality as measured by the PSQI questionnaire (Z = 2.53, p =.010). Patient-reported experience was consistently positive and revealed additional relevant aspects from this perspective. Conclusion: HNS therapy significantly improves quality of life in patients with OSA and reliably produces clinically meaningful effects on daytime sleepiness, daytime functioning, and sleep quality. Treatment regularly meets or exceeds the minimum clinically important differences defined for the respective instruments. Additional research is needed to further investigate effects on quality of life beyond improvements in daytime sleepiness and daytime functioning.
AB - Introduction: Hypoglossal nerve stimulation (HNS) has recently been introduced as an alternative treatment for patients with OSA. A large number of studies have demonstrated substantial changes in OSA with this therapy by reducing respiratory events and improving symptoms such as daytime sleepiness and quality of life. The objective of this review was to conduct a systematic review and meta-analysis to evaluate patient-reported outcomes and experience with HNS therapy. Methods: A systematic literature search of MEDLINE, Cochrane, and Web of Science was performed to identify randomized controlled and observational studies reporting subjective outcomes with different HNS systems in patients with OSA. Abstracts of 406 articles were screened and a subset of 55 articles were reviewed for eligibility. Risk of bias was assessed using the ROBINS-I tool. Meta-analysis using RevMan was performed when > 2 studies were identified that reported data on a specific outcome. Results: Thirty-four publications reporting data on 3785 patients with a mean follow-up of 11.8 ± 12.2 months were identified and included in the meta-analysis. The analysis revealed a pooled effect of 4.59 points improvement in daytime sleepiness as measured by the ESS questionnaire (Z = 42.82, p <.001), 2.84 points improvement in daytime functioning as measured by the FOSQ score (Z = 28.38, p <.001), and 1.77 points improvement in sleep quality as measured by the PSQI questionnaire (Z = 2.53, p =.010). Patient-reported experience was consistently positive and revealed additional relevant aspects from this perspective. Conclusion: HNS therapy significantly improves quality of life in patients with OSA and reliably produces clinically meaningful effects on daytime sleepiness, daytime functioning, and sleep quality. Treatment regularly meets or exceeds the minimum clinically important differences defined for the respective instruments. Additional research is needed to further investigate effects on quality of life beyond improvements in daytime sleepiness and daytime functioning.
KW - Quality of life
KW - Sleep surgery
KW - Sleep-disordered breathing
KW - Technology assessment
UR - http://www.scopus.com/inward/record.url?scp=85162911758&partnerID=8YFLogxK
U2 - 10.1007/s00405-023-08062-1
DO - 10.1007/s00405-023-08062-1
M3 - Review article
C2 - 37354340
AN - SCOPUS:85162911758
SN - 0937-4477
VL - 280
SP - 4627
EP - 4639
JO - European Archives of Oto-Rhino-Laryngology
JF - European Archives of Oto-Rhino-Laryngology
IS - 10
ER -